Conference Proceedings
Safety and Activity of the Highly Specific BTK Inhibitor BGB-3111 in Patients with Indolent and Aggressive Non Hodgkin's Lymphoma
Constantine S Tam, David Simpson, Stephen Opat, Won Seog Kim, Michael Wang, Gavin Cull, Patrick B Johnston, Javier Munoz, Won-Sik Lee, Paula Marlton, David Gottlieb, Lai Wang, Jane Huang, James Hilger, Ling Xue, Sunhee Ro, Judith Trotman
BLOOD | AMER SOC HEMATOLOGY | Published : 2017
Grants
Funding Acknowledgements
Tam: Roche: Honoraria, Research Funding; Abbvie: Honoraria, Research Funding; Janssen Cilag: Honoraria, Research Funding. Simpson: Celgene: Honoraria, Other: travel expenses; Pharmacyclics LLC, an AbbVie Company: Research Funding; Onyx: Research Funding; Roche: Honoraria; Amgen: Research Funding. Opat: Roche: Consultancy, Honoraria, Research Funding, Speakers Bureau; Gilead: Consultancy, Honoraria, Research Funding, Speakers Bureau; Janssen: Consultancy, Honoraria, Speakers Bureau; Beigene: Research Funding; Mundipharma: Consultancy; Amgen: Research Funding. Kim: Roche: Research Funding; Novartis: Research Funding; Kyowa-Kirin: Research Funding; Donga: Research Funding; Takeda: Research Funding; Celltrion, Inc: Consultancy, Honoraria; Mundipharma: Research Funding; J&J: Research Funding. Wang: Proteolix: Honoraria, Research Funding; Pharmacyclics: Research Funding; Onyx: Research Funding; Kite Pharma: Research Funding; Juno Therapeutics: Research Funding; Janssen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Dava Oncology: Honoraria; Celgene: Honoraria, Research Funding; BeiGene: Research Funding; Asana Biosciences: Research Funding; Acerta Pharma: Consultancy, Research Funding. Cull: Amgen Australia: Other: travel expenses Lugano lymphoma conference 2017; Takeda Australia: Other: travel expenses Highlights of ASH march 2017, Brisbane. Munoz: Kite Pharma: Consultancy, Speakers Bureau; Bayer: Consultancy; Pharmacyclics: Consultancy; Alexion: Consultancy. Gottlieb: Indee: Membership on an entity's Board of Directors or advisory committees; Abbvie: Membership on an entity's Board of Directors or advisory committees. Wang: BeiGene: Employment. Huang: BeiGene: Employment. Hilger: BeiGene: Employment. Xue: BeiGene: Employment. Ro: BeiGene: Employment. Trotman: Roche: Membership on an entity's Board of Directors or advisory committees, Other: All positions non-remunerated, Speakers Bureau; Celgene: Membership on an entity's Board of Directors or advisory committees, Other: Funding facilitating research paid to third parties. All positions non-remunerated; Takeda: Membership on an entity's Board of Directors or advisory committees, Other: Position non-remunerated; Janssen Cilag: Membership on an entity's Board of Directors or advisory committees, Other: Funding facilitating research paid to third parties. All positions non-remunerated, Speakers Bureau.